Published January 28, 2025
| Version v1
Journal article
Open
Progesterone induces meiosis through two obligate co-receptors with PLA2 activity
Creators
- 1. Weill Cornell Medicine Qatar
- 2. University of Chicago
Description
The steroid hormone progesterone (P4) regulates multiple aspects of reproductive and metabolic physiology. Classical P4 signaling operates through nuclear receptors that regulate transcription. In addition, P4 signals through membrane P4 receptors (mPRs) in a rapid nongenomic modality. Despite the established physiological importance of P4 nongenomic signaling, the details of its signal transduction cascade remain elusive. Here, using Xenopus oocyte maturation as a well-established physiological readout of nongenomic P4 signaling, we identify the lipid hydrolase ABHD2 (α/β hydrolase domain-containing protein 2) as an essential mPRβ co-receptor to trigger meiosis. We show using functional assays coupled to unbiased and targeted cell-based lipidomics that ABHD2 possesses a phospholipase A2 (PLA2) activity that requires mPRβ. This PLA2 activity bifurcates P4 signaling by inducing clathrin-dependent endocytosis of mPRβ, resulting in the production of lipid messengers that are G-protein coupled receptor agonists. Therefore, P4 drives meiosis by inducing an ABHD2 PLA2 activity that requires both mPRβ and ABHD2 as obligate co-receptors.
Data availability
All data generated or analysed during this study are included in the manuscript and associated source data files. The metabolomics datasets in the source data tables include the metabolomics and lipidomics platforms used as explained in details in the methods section.Files
elife-92635-v1.pdf
Files
(20.2 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:367d6eb939ebb3fd306d065121b1d69f |
7.1 MB | Preview Download |
|
Supplementary files md5:001c04fa67a289e3751732a25dad9790 |
13.1 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.7554/eLife.92635.3
- Other
- oai:uchicago.tind.io:14485
Funding
- Qatar Foundation
- BMRP
- Qatar National Research Fund
- NPRP13S-0206-200274
- National Institutes of Health
- R01AR076029
- National Institutes of Health
- R21ES032347